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Abstract
Despite rapid advances in disease gene identification, the predictive power of the genotype
remains limited, in part due to poorly understood effects of second-site modifiers. Here we
demonstrate that a polymorphic coding variant of RPGRIP1L (retinitis pigmentosa GTPase
regulator-interacting protein-1 like), a ciliary gene mutated in Meckel-Gruber (MKS) and Joubert
(JBTS) syndromes, is associated with the development of retinal degeneration in patients with
ciliopathies caused by mutations in other genes. As part of our resequencing efforts of the ciliary
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proteome, we identified several putative loss of function RPGRIP1L mutations, including one
common variant, A229T. Multiple genetic lines of evidence showed this allele to be associated
with photoreceptor loss in ciliopathies. Moreover, we show that RPGRIP1L interacts
biochemically with RPGR, loss of which causes retinal degeneration, and that the 229T-encoded
protein significantly compromises this interaction. Our data represent an example of modification
of a discrete phenotype of syndromic disease and highlight the importance of a multifaceted
approach for the discovery of modifier alleles of intermediate frequency and effect.
The ciliopathies are a collection of disorders with overlapping clinical manifestations that
include renal cystic disease, polydactyly, retinal degeneration and defects of the central
nervous system1, and provide a useful model to investigate both the effects of variation at a
single locus and the potential epistatic interactions between alleles at functionally related
loci. This is because several ciliopathy-causing genes can either cause a distinct recessive
form of ciliary disease or contribute modulators of penetrance and expressivity. In some
instances, multiple allelism at a single locus can partially explain phenotypic variability. For
example, null mutations in NPHP3 cause MKS2, while hypomorphic NPHP3 alleles cause
Nephronophthisis (NPHP)3. Similarly, hypomorphic CEP290/NPHP6 mutations are
observed frequently in Leber congenital amaurosis (LCA) in both humans and in a mouse
model4,5, whereas loss-of-function mutations lead to a constellation of ciliopathies that
include MKS, NPHP, Bardet-Biedl Syndrome (BBS) and JBTS6-9 without a clear
explanation for the phenotypic variation.
Consistent with the suggestion of second-site modifiers, several alleles are reported to
modify ciliary phenotypes; a hypomorphic mutation in MGC1203 contributes to the overall
penetrance and expressivity of BBS10, while heterozygous variants in CEP290 and AHI1
contribute to the phenotypic severity and pleiotropy of NPHP11. Finally, likely additive
effects between alleles in bona fide BBS and MKS loci produce hybrid phenotypes of the
two clinical entities7.
A paradigm emerging from the above studies is that genes mutated in one ciliopathy may
contribute alleles across the entire clinical spectrum and that the assessment of total
mutational load across the ciliary proteome12,13 will help dissect phenotypic causality and
variability. Towards this end, we have initiated two complementary strategies – interactome
studies on ciliary proteins and medical resequencing of known ciliopathy genes across a
cohort of patients with diverse phenotypes (MKS and JBTS as severe, BBS as intermediate,
NPHP and LCA as mild).
We first investigated RPGRIP1L, under the hypothesis that in addition to its association
with MKS and JBTS14,15, it might also contribute alleles to other ciliary disorders. We
screened 166 unrelated patients of northern European descent (17 MKS, 15 NPHP (with and
without extra-renal phenotypes), 34 BBS, 100 LCA) and discovered 10 different novel
nonsynonymous changes in 24 individuals (Table 1). We also detected two different
common variants G1025S (rs2111119) and D1264N (rs3213758), both of which are present
at similar allele frequencies when compared across our ciliopathy cohort, a cohort of 96
control individuals of northern European descent, and 60 CEPH controls from HapMap
(data not shown).
None of the observed alleles are sufficient to explain disease manifestation under a
Mendelian model. However, most alleles were either unique to our patient population, or
were enriched compared to ethnically matched controls, and mapped within known
functional domains of RPGRIP1L (Table 1; Suppl. Fig. 1).
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However, the rarity of most alleles precluded us from delineating their impact on the clinical
phenotypes. One notable exception, A229T, is sufficiently frequent to empower such a
study. To assess allele neutrality without a preconceived model of inheritance, we performed
Transmission Disequilibrium Testing (TDT); we screened 145 BBS families for which DNA
was available from both parents. Focusing on families in which only one of the two parents
was an A229T heterozygote, we identified 18 informative trios and detected significant
over-transmission of the threonine-encoding allele in patients (15/18 transmissions; 83.3%,
p<0.01).
Despite the modest number of trios, the TDT suggested that the A229T change is not
neutral. To probe this possibility further, we re-evaluated our original resequencing data. We
found a surprising enrichment of the 229T allele in northern European patients in whom
retinal degeneration is mandatory for diagnosis, such as in BBS or Senior-Loken Syndrome
(SLS) (5.9%; 4/68 chromosomes, and 15%; 3/20 chromosomes respectively; Table 1,
compared to a 2.8% allele frequency in unaffected northern Europeans; Table 2). We
therefore wondered whether this variant might contribute to the retinal defect, which is a
frequent, but not ubiquitous, ciliopathy phenotype. If this is true, then comparisons between
NPHP (no retinal degeneration) versus SLS cohorts (NPHP and retinal degeneration) should
be informative. Even though each of these phenotypes is rare in the general population, we
were able to study two northern European cohorts: 66 unrelated patients with isolated NPHP
and 84 patients with SLS. Remarkably, 229T was absent from the NPHP group, but was
detected at an allele frequency of 5.4% in SLS patients (Table 2). The small size of this
cohort precluded meaningful statistical analysis. Nonetheless, these data suggested that the
absence of 229T might have a protective effect from RP.
To investigate this possibility, we queried whether the 229T allele frequency is significantly
different in a larger case-control cohort of northern European ciliopathy patients (Suppl.
Table 1). We categorized our patients into two groups, with retinal phenotypes being the
sole distinguishing factor. Both groups exhibited significantly different 229T allele
frequencies compared to controls (n=3016 control alleles); the allele was absent from the
non-retinal degeneration group (n=230 alleles; p=1.92E-03) but was enriched in the retinal
degeneration group (combined: 4.5%, n=974 alleles, p=6.45E-03; Table 2). Furthermore, in
agreement with our earlier data, we observed significantly different 229T allele frequencies
between the non-retinal pathology and retinal degeneration ciliopathy groups (p=7.35E-05;
Table 2). To evaluate the statistical significance of our findings further, we performed
permutation analyses where the observed genotypes in the entire sample were assigned
randomly without replacement in the three groups (ciliopathy +RP, ciliopathy −RP,
controls). After 107 independent random assignments, we counted the number of times that
the differences in minor allele frequency in each group matched or exceeded the actual
differences. This study provided additional evidence that the association data did not occur
by chance (Table 2). Importantly, we found A229T to be transmitted through at least three
different haplotypes (three patients contained unique RPGRIP1L SNPs in cis with 229T),
while the frequency of 229T was indistinguishable across cohorts collected at different sites
(Suppl. Table 1), arguing against a stratification artifact.
Our genetic data suggest a role for 229T in the development of RP in ciliopathy patients.
However, the low frequency of this allele in the population and its apparent modest effect in
our cohorts limit the power of genetic studies. We therefore evaluated the potential
consequences of A229T to protein function.
As a first test, we performed a genetic rescue experiment using an in vivo model. We have
shown previously that suppression of ciliary and basal body proteins in zebrafish leads to
measurable phenotypes in mid-somitic embryos, some of which are caused by defects in
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Wnt signaling16,17, a phenotype also observed in other experimental ciliopathy models18.
The ability of human mRNA to rescue somitic phenotypes has proven useful for establishing
the pathogenic potential of alleles by comparing the efficiency of rescue of wild type (wt)
human messenger RNA (mRNA) compared to mRNA bearing the missense variant(s) under
investigation7. We identified a single partial zebrafish transcript that, upon reciprocal
BLAST analysis, showed the highest amino acid similarity between zebrafish and human
(73% similarity, 55% identity), to which we designed a splice-blocking morpholino (MO).
The MO was injected into wild-type (wt) embryos at the two-cell stage (50-100 embryos per
injection) and scored at the eight to nine somite stage. Consistent with data from other
ciliopathy genes7,10,16,17, we observed dose-dependent gastrulation defects that included a
shortened body axis, thin somites with broad lateral extensions, minor kinking of the
notochord, underdeveloped anterior structures and tail extension abnormalities, all of which
enabled us to categorize embryos into two classes based on objective criteria (Class I or
Class II; Fig. 1a; Suppl. Fig. 2a). These phenotypes resulted from loss of rpgrip1l, since RT-
PCR and sequencing analysis of embryos showed 10 ng of MO to cause ᙺ50% reduction of
rpgrip1l mRNA (Suppl. Fig. 2b). Importantly, the phenotypes could be rescued by co-
injection of 50 pg of wt human mRNA (embryos scored blind to injection cocktails; Fig. 1b,
Suppl. Table 2).
We therefore proceeded to compare the efficiency of rescue between human mRNA
encoding each of 229A and 229T. In addition, we included two known pathogenic missense
alleles, T615P and A695P, that cause JBTS14,15 as positive controls, as well as the neutral
G1025S variant as a negative control. Embryos were co-injected with a cocktail of MO and
each human mRNA (n=88-115 embryos per allele) and scored blind to the injection cocktail
(Suppl. Table 2). We found that the 229T rescue gastrulation phenotype was significantly
different from wt mRNA rescue (p<0.0001; Fig1b, Suppl Table 2). The assay was specific,
since each of T615P and A695P were scored as pathogenic, but had no off-target effects; the
rescue of the 1025S-encoding mRNA was indistinguishable from the 1025G message
(Fig1b).
To substantiate these assessments, we measured embryonic structures labeled in situ with
pax2, krox20, and myoD riboprobes. On whole embryo flat-mounts age-matched to eight to
nine somites, we calculated the ratio of the width (w) spanning the distal ends of the 5th
somites to the length (l) of the notochord as demarcated by adaxial cell labeling (n=8-20
embryos measured per variant). Consistent with our live embryo scoring, comparison of the
mean w/l ratios between wt and mutant rescues indicated that both positive control alleles
and A229T, but not G1025S, are pathogenic (Fig. 1c, d; Suppl. Table 3).
As a third line of in vivo evidence, we examined 5-day rpgrip1l morphant larvae (n=52-78
embryos/injection). Consistent with other ciliopathy morphants19, we observed tail
extension abnormalities in 35% of rpgrip1l morphants, which was rescued by co-injection of
wt human RPGRIP1L message (Fig. 1e, f). However, mRNA encoding 229T was unable to
efficiently rescue the tail phenotype (p=0.031), consistent with both the T615P and A695P
rescues (p=0.001 and 0.004 respectively). These observations, in addition to the absence of
tail phenotypes in morphants rescued with G1025S mRNA, substantiated further the
specificity of our assay (Fig. 1e, f).
We next turned to the question of why A229T might have the observed effect on the retinal
degeneration phenotype. We noted that mutations in one of the NPHP genes, NPHP5, are
also associated with an increased incidence of SLS; all tested patients with NPHP5 null
variants exhibit retinal degeneration compared to a 10% incidence of retinopathy in patients
with mutations in other NPHP-associated genes20. NPHP5 interacts with RPGR20, a ciliary
protein mutated in 70-80% of X-linked RP and 20-25% of simplex RP21-24. We therefore
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hypothesized that RPGRIP1L might also interact biochemically with RPGR and that the
A229T allele might have a measurable effect on the affinity of this interaction. As part of
our ongoing efforts to understand the pathobiology of RPGR, we had performed yeast two-
hybrid (Y2H) screens of human retinal cDNA as prey using full-length RPGRORF15 as bait
and identified the carboxyl-terminal domain of RPGRIP1L (RPGR-interacting domain;
RID); this interaction was validated by known-bait and known-prey analysis using different
domains of RPGR as bait (Fig. 2a, b). To corroborate the findings, we generated an anti-
human RPGRIP1L antibody (Suppl. Fig. 3) and performed co-immunoprecipitations (IP)
using bovine retinal extracts. In reciprocal IP experiments with RPGRIP1L or RPGR
antibody, we detected the expected bands on immunoblots corresponding to RPGR or
RPGRIP1L, respectively (Fig. 2c). Co-transfection of COS-1 cells followed by co-IP
demonstrated that Xpress-tagged RPGR and GFP-RPGRIP1L proteins are part of the same
complex (Fig. 2d). We then tested A229T and three reported JBTS variants14,15 that are
shown to be pathogenic in our zebrafish assay. Triplicate experiments showed that the GFP-
tagged A229T mutant protein showed considerably lower (ᙺ80%) ability to
immunoprecipitate RPGR and has a profound effect on RPGR binding compared to the
JBTS mutations (Fig. 2e, f). We also found that RPGRIP1L localizes to the cilium and basal
body of mouse IMCD3 cells and to the inner segment/connecting cilium of mouse
photoreceptors (Suppl. Fig. 4), in the same spatiotemporal context as demonstrated
previously for RPGR4,23,24. Hence, the abrogation of RPGRIP1L-RPGR interaction is
likely to be relevant in photoreceptors.
Second-site modifications are emerging as prevalent phenomena in Mendelian disorders. For
example, PLS3 is a protective modulator of SMN1 dysfunction associated with Spinal
Muscular Atrophy (SMA)25; mutations in CNTF modify the age of onset in amyotrophic
lateral sclerosis (ALS)26, while a mutation in MGC1203 can modify the global penetrance/
expressivity in BBS10. However, the penetrance and expressivity of tissue-specific defects
within the context of syndromic disease pose a considerable challenge, especially for alleles
of modest frequency in the general population and modest effect on the phenotype, which
cannot be captured by traditional population-based genetic tools. Our data suggest that, in
patients of northern European descent, the presence of the 229T allele of RPGRIP1L has
predictive value for retinal degeneration. It will be important to consider the nature and
position of mutations at the primary locus, since A229T probably exerts its effect in the
context of mutations in specific ciliopathy proteins that can complex with RPGR in the
retina; this is consistent with the previously proposed poison model of genetic epistasis27.
It is possible that some of the other alleles reported herein might also exhibit a similar effect;
however, their rarity will necessitate the evaluation of larger cohorts. Notably, in vivo
evaluation of each of the rare alleles using the zebrafish rescue assay suggested that most are
pathogenic (Table 3, Suppl. Table 2, Suppl. Table 3, Suppl. Fig 5) and that they can
potentially interact with alleles at various sites of the ciliopathy genetic spectrum (Table 1).
Also, destabilization of the RPGRIP1L-RPGR complex is unlikely to be the sole cause of
retinal degeneration. RPGRIP1L also associates with RPGRIP1 (Fig. 2c), null mutations in
which cause early-onset, severe retinal degeneration28. Three of the alleles found in our
cohort, A1183G, R1236C and D1264Y map within the RPGRIP1-interacting domain of
RPGRIP1L; hence, their contribution to disease might be mediated by loss of RPGRIP1
activity/function. Finally, RPGRIP1L and RPGR are members of a larger macromolecular
complex whose composition and function will vary across tissue types and ciliary functions.
Establishment of the content and the stoichiometry of such complex(es), coupled to the
evaluation of ciliopathy alleles on the stability of the macromolecular complex in a tissue/
function-dependent manner will enable the currently poor allelic stratification of variability
in disease phenotypes.
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Methods
Ciliopathy patients, controls, and mutational analysis
Control DNAs were obtained from healthy individuals with no clinical ciliopathy criteria
(retinal degeneration, polydactyly, renal abnormalities, mental retardation or other central
nervous system defects) from four collection points (Suppl. Table 1). Blood samples were
obtained following informed consent. We amplified the exon sequence and intron/exon
junctions of RPGRIP1L (NM_015272) from DNA extracted from lymphoblast cell lines or
lymphocytes according to standard protocols. PCR products were sequenced with BigDye
Terminator v3.1 chemistry on an ABI 3100 or ABI 3730 (Applied Biosystems), sequences
were analyzed with PolyPhred, and variants were confirmed by resequencing and visual
assessment of chromatograms. Primer sequences and PCR conditions are available upon
request.
Statistical analyses
We used plink v1.04 (http://pngu.mgh.harvard.edu/purcell/plink/) for TDT analysis in BBS
trios, and the PEPI404x package for Fisher's exact test. All other analyses were performed in
Microsoft Excel.
DNA constructs
We generated full-length or specific domains of RPGR by PCR from retinal cDNA and
subcloned them into the pcDNA 4 expression vector (Invitrogen). Full-length RPGRIP1L
was amplified from human retinal cDNA, cloned into expression vector pEGFP-C1 (in vitro
assays) or pCS2+ (in vivo assays) and confirmed by direct sequencing. Mutagenesis was
performed using the QuickChange Site-Directed Mutagenesis kit (Stratagene), according to
manufacturer's instructions.
Zebrafish embryo manipulation and morpholino injection
A splice-blocking MO (Gene Tools) was diluted to appropriate concentrations in deionized,
sterile water (2, 4, 6, 8, and 10ng/nl for the dose response, and 10ng/nl for rescue
experiments) and was injected into wt zebrafish embryos at the two-cell stage as
described10. To rescue the MO phenotype, we transcribed mRNA from linearized pCS2+-
RPGRIP1L vector with the SP6 mMessage machine kit (Ambion). We carried out in situ
hybridization on whole embryos fixed with 4% paraformaldehyde with riboprobes against
pax2, krox20, and myoD using standard protocols. Images were captured at 10X
magnification and measurements were taken of the width spanning the 5th somites from the
anterior end, and the length of the notochord as defined by myoD staining of adaxial cells.
Embryos used for assessment of tail phenotypes at 5dpf were reared in 1-phenyl-2-thiourea
(PTU)-treated embryo media, and anesthetized with Tricaine for imaging at 4X
magnification. MO efficiency was determined by extracting total RNA from embryos with
Trizol (Invitrogen) according to manufacturer's instructions. Oligo-dT-primed total RNA
was reverse transcribed using SuperScriptIII reverse transcriptase (Invitrogen) and cDNA
was subsequently PCR amplified and sequenced using standard procedures.
Yeast two-hybrid screen
We carried out the yeast two-hybrid (Y2H) analysis using the Matchmaker Gal4-two hybrid
system (Clontech), according to manufacturer's instructions. We amplified the full-length
cDNA of mouse RpgrORF15 or its different domains and cloned into the bait vector
pGBKT7. The adult human retinal cDNA library was cloned into the ‘prey’ pGADT7 vector
(Clontech) and used for the screen. Known-bait and known-prey analysis was carried out as
described29.
Khanna et al. Page 6
Nat Genet. Author manuscript; available in PMC 2009 December 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Antibodies
Characterization of the ORF15CP antibody has been described24. Anti-RPGRIP1L antibody
was generated by immunizing rabbits with the human
peptide 1300HALQSVYKQYRDDLE1314 (Yenzym). RPGRIP1 antibody was a gift from Dr.
Tiansen Li (Harvard Medical School); Antibodies against Xpress-tag and acetylated ͣ-
tubulin were procured from Invitrogen and Chemicon, respectively.
Mammalian cell culture, transient transfection, co-immunoprecipitation (coIP) and
immunolocalization
We propagated COS-1 cells in DMEM plus 10%FBS, supplemented with Penicillin,
Streptomycin and L-Glutamine. Co-IP experiments from retina and transfected cells have
been described24. Immunolocalization studies in cells and in the retinal sections were
carried out as reported previously4,30.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Functional assessment of the RPGRIP1L A229T variant in vivo
a. Zebrafish embryos injected with rpgrip1l splice-blocking morpholino (MO) display
gastrulation defects at the eight-nine somite stage; lateral and dorsal views of live embryos
are shown. Embryos were categorized phenotypically based on the presence of a shortened
body axis (anterior and posterior ends indicated with blue triangles) and small head/eyes
only (magenta lines indicate eye size) (Class I; mild); or shortened body axis and small
head/eyes in addition to at least one of the following: broad and thin somites (white line
indicates somite span), notochord kinking, and tail extension defects (black asterisk) (Class
II; severe).
b. Live scoring of embryos co-injected with MO and human RPGRIP1L mRNA indicates
that A229T is pathogenic in our assay as indicated by the comparison of WT rescue
efficiency to mutant rescue efficiency. MO, morpholino alone; WT, wild-type human
RPGRIP1L mRNA. Known JBTS mutations T615P and A695P are positive controls; neutral
variant G1025S (rs2111119) is a negative control. Statistical significance (mutant rescue vs.
WT rescue) is depicted as (***), p<0.0001 (͹2); see Suppl Table 2 for all ͹2 and p-values.
c. Representative examples of whole-mount embryos hybridized in situ with pax2, krox20,
and myoD riboprobes.
d. Two-dimensional morphometric quantification of the efficiency of human RPGRIP1L
mRNA to rescue rpgrip1l MO phenotypes. Whole embryos with eight-nine appreciable
somites (n=8-20/injection) labeled with pax2, krox20, and myoD riboprobes were flat-
mounted, photographed and measured in two dimensions. The width/length ratio was
calculated as the width (w) spanning between the distal ends of the 5th anterior somites
(horizontal arrow in panel c) vs. the length (l) of the notochord as indicated by the staining
of adaxial cells (vertical arrow in panel c). Statistical significance (mutant vs. WT rescue) is
depicted as (*), p<0.05 and (***), p<0.0001 (two-tailed student's t-test); see Suppl Table 3
for all p-values.
e. rpgrip1l morphant larvae display tail development defects at 5 days post-fertilization
(dpf). Morphant larva (MO) with tail curvature and posterior structural disorganization can
be rescued efficiently with WT human RPGRIP1L mRNA, however RPGRIP1L message
harboring the 229T encoding allele does not completely rescue the tail phenotype.
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f. Quantification of the efficiency of tail phenotype rescue in 5dpf larvae. Whereas WT
RPGRIP1L message completely rescued the tail phenotypes, A229T as well as positive
controls T615P and A695P result in the persistence of affected tail structures in injected
larva. G1025S was used as a negative control. Statistical significance (mutant rescue vs. WT
rescue) is depicted as (*), p<0.05 (͹2).
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Figure 2. RPGRIP1L interacts with RPGR and missense variant A229T abrogates this
interaction
a. Known-bait and known-prey analysis. Yeast two-hybrid analysis using indicated RPGR
bait-encoding constructs and RPGRIP1L [carboxyl-terminal (C) or full-length (FL)] prey
encoding constructs revealed interaction of RPGR exons 1-11 with carboxyl-terminal or
full-length RPGRIP1L. Laminin was used as negative control, whereas p53/T-antigen (T-
Ag) interaction served as a positive control.
b. RPGR-RPGRIP1L interaction was validated further by examining the activation of the
LacZ gene in the ͤ-galactosidase assay corresponding to (a).
c. Interaction of RPGR and RPGRIP1L in vivo. Bovine retinal extracts were subjected to
immunoprecipitation (IP) using anti-RPGR, RPGRIP1, RPGRIP1L antibodies, normal
immunoglobulin (IgG), or pre-immune serum (Pre-Imm). Precipitated proteins were
analyzed by SDS-PAGE and immunoblotting (IB) using anti-RPGRIP1L (left) or RPGR-
ORF15CP antibody (right). Arrow (left) indicates RPGRIP1L-imunoreactive band and the
straight line in the right panel depicts the RPGR isoforms pulled down by RPGRIP1L.
Asterisk (*) marks a non-specific immunoreactive band.
d. RPGR-RPGRIP1L interaction in transfected cells. COS-1 cells were transiently
transfected with constructs encoding Xpress-tagged RPGR, GFP-RPGRIP1L or Xpress-tag
alone. Proteins were extracted and subjected to immunoprecipitation (IP) using the anti-GFP
antibody. Precipitated proteins were analyzed by SDS-PAGE and immunoblotting using
anti-Xpress antibody. Input lane contains 20% of the protein extract used for IP. Arrow
indicates the Xpress-immunoreactive band.
e. Interaction of RPGR with wild-type (WT) and mutant RPGRIP1L. COS-1 cells were
transiently transfected with constructs encoding WT or mutant RPGRIP1L fused to GFP and
Xpress-tagged RPGR. Panels ‘a’ and ‘b’ indicate the 20% of the GFP-RPGRIP1L and
Xpress-RPGR input protein extract used for IP. Precipitation of GFP-RPGRIP1L using the
GFP antibody was used as a positive control (panel ‘c’). Association of wt and mutant GFP-
RPGRIP1L with Xpress-RPGR is represented in Panel ‘d’. T677I represents a bona fide
pathogenic allele, but which likely does not contribute to retinal degeneration.
f. Quantitative analysis of the band intensities are represented as percent of mutant
RPGRIP1L immunoprecipitated by RPGR. Association of wt GFP-RPGRIP1L with RPGR
was considered as 100%. The results represent an average of three independent experiments.
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Table 1
Total mutational load in northern European ciliopathy patients with RPGRIP1L variants
Clinical
Diagnosis
Patient
ID
RPGRIP1L
Alleles
Allele
Frequency in
Controls
Other Alleles
LCA 3184 S199G 0/192
LCA 340 A229T 84/3016 RPGR: I1148V het
LCA 341 A229T A229T 84/3016 LCA5: Q279X het
LCA 1972 L546F 0/192
LCA 1321 V647I 0/192 CRB1: C948Y hom
LCA 1378 T677I 0/260 RPGRIP: R890X hom
LCA 1380 T677I 0/260
LCA 1617 R937L 0/192
LCA 3182 A1183G 4/192 RPGR: I1148V het
LCA 3189 A1183G 4/192 RPGR: I1148V het, N1081K het
LCA 3181 D1264Y 0/192 RPGR: I1148V het
LCA 3187 D1264Y 0/192 RPGR: I1148V het
LCA 3192 D1264Y 0/192
SLS F259-II1 A229T 84/3016 NPHP5: R364X het
SLS F848-II1 A229T 84/3016 NPHP5: T627M het, CEP290: R1978X het
SLS F99-II1 A229T 84/3016 NPHP3: R397H het, S500P het
JBTS F256-II1 A229T 84/3016 CEP290: Q1591X het
BBS AR74-05 A229T 84/3016
BBS AR400-03 A229T 84/3016
BBS AR672-03 A229T 84/3016
BBS AR775-03 A229T 84/3016 MKS1: D286G het
BBS AR348-03 L447S 0/192
BBS AR623-03 A1183G 4/192
MKS MKS-060143 R1236C 0/192
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Table 2
Frequency of RPGRIP1L A229T (c.685G>A; rs61747071) in ciliopathy patients of northern European descent
Clinical
Diagnosis n=
Genotype
Counts
Genotype
Frequency
Allele
Counts
Allele
Frequency
p-values
Cases v.
Controls1
RP v.
Non-RP1
Cases v.
Controls2
RP v.
Non-RP2
GG GA AA GG GA AA G A G A
Controls 1508 1425 82 1 0.945 0.054 0.001 2932 84 0.972 0.028
NPHP 66 66 0 0 1 0 0 132 0 1 0
MKS 49 49 0 0 1 0 0 98 0 1 0
Ciliopathy Non-RP 115 115 0 0 1 0 0 230 0 1 0 1.92E-03 1.54E-03
LCA 189 174 14 1 0.921 0.074 0.005 362 16 0.958 0.042
SLS 84 75 9 0 0.893 0.107 0 159 9 0.946 0.054
JBTS 30 25 5 0 0.833 0.167 0 55 5 0.917 0.083
BBS 184 170 14 0 0.924 0.076 0 354 14 0.962 0.038
Ciliopathy RP 487 444 42 1 0.912 0.086 0.002 930 44 0.955 0.045 6.45E-03 7.35E-05 0.021 1.66E-05
1
Fisher's exact test, 1-tailed; 2-tailed p-values remained significant (Ciliopathy Non-RP v. Controls, p=3.84E-03; Ciliopathy RP v. Controls, p=0.013; Ciliopathy Non-RP v. Ciliopathy RP, p=1.47E-04)
2
Permutation test
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Table 3
Functional assessment of RPGRIP1L missense variants in an in vivo zebrafish model
Conservation In vivo modeling in zebrafish
Variant Domains* Species** Live scoring Quantitative
S199G CCI Ptr, Bta, Cfa, Mmu, Oan, Dre pathogenic pathogenic
A229T CCI Ptr, Mmul, Eca, Bta, Cfa, Rno, Mmu, Mdo, Dre pathogenic pathogenic
L447S CCIV Ptr, Mmul benign benign
L546F CCV Ptr, Mmul, Eca, Bta, Cfa, Rno, Mmu, Mdo, Oan, Gga, Dre pathogenic pathogenic
T615P C2 Ptr, Mmul, Eca, Bta, Cfa, Mmu, Mdo pathogenic pathogenic
V647I C2 Ptr, Mmul, Mdo, Oan, Gga, Dre, Spu pathogenic benign
T677I C2 Ptr, Mmul, Eca, Bta, Cfa, Rno, Mmu, Oan pathogenic pathogenic
A695P C2 Ptr, Mmul, Eca, Bta, Cfa, Rno, Mmu, Mdo, Oan, Dre, Spu pathogenic pathogenic
R937L Ptr, Mmul, Cfa pathogenic pathogenic
A1183G RID Ptr, Mmul, Eca, Bta, Cfa, Rno, Mmu, Mdo, Oan, Gga pathogenic pathogenic
R1236C RID Ptr, Mmul, Eca, Bta, Cfa, Rno, Mmu, Mdo, Oan, Spu pathogenic pathogenic
D1264Y RID Eca, Bta, Cfa, Rno, Mmu pathogenic pathogenic
*CC- Coiled coil domain; C2- protein kinase C (PKC) conserved region 2 motif; RID- domain with homology to the RPGR-interacting domain of
RPGRIP1.
**
Ptr- Pan troglodytes; Mmul- M. mulatta; Eca- E. caballus; Bta- B. taurus; Cfa- C. familiaris; Rno- R. norvegicus; Mmu- M. musculus; Mdo- M.
domestica; Oan- O. anatinus; Gga- G. gallus; Dre- D. rerio; Spu- S. purpuratus
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